- $28.25bn
- $29.49bn
- $8.56bn
- 95
- 32
- 90
- 85
Annual balance sheet for Xylem, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,875 | 1,349 | 944 | 1,019 | 1,121 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 923 | 953 | 1,096 | 1,617 | 1,668 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,523 | 3,160 | 3,012 | 3,884 | 4,098 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 929 | 948 | 940 | 1,602 | 1,558 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 8,750 | 8,276 | 7,952 | 16,112 | 16,493 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,956 | 1,391 | 1,590 | 2,205 | 2,336 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 5,782 | 5,058 | 4,458 | 5,946 | 5,851 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 2,968 | 3,218 | 3,494 | 10,166 | 10,642 |
Total Liabilities & Shareholders' Equity | 8,750 | 8,276 | 7,952 | 16,112 | 16,493 |
Total Common Shares Outstanding |